These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Synergistic effects of cagA+ Helicobacter pylori co-infected with Opisthorchis viverrini on hepatobiliary pathology in hamsters. Suyapoh W; Tangkawattana S; Suttiprapa S; Punyapornwithaya V; Tangkawattana P; Sripa B Acta Trop; 2021 Jan; 213():105740. PubMed ID: 33159904 [TBL] [Abstract][Full Text] [Related]
44. Involvement of MMP-9 in peribiliary fibrosis and cholangiocarcinogenesis via Rac1-dependent DNA damage in a hamster model. Prakobwong S; Yongvanit P; Hiraku Y; Pairojkul C; Sithithaworn P; Pinlaor P; Pinlaor S Int J Cancer; 2010 Dec; 127(11):2576-87. PubMed ID: 20162672 [TBL] [Abstract][Full Text] [Related]
45. Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma: Association of diabetes mellitus and cholangiocarcinoma. Saengboonmee C; Seubwai W; Wongkham C; Wongkham S Cancer Epidemiol; 2015 Jun; 39(3):274-8. PubMed ID: 25910864 [TBL] [Abstract][Full Text] [Related]
46. A tumorigenic cell line derived from a hamster cholangiocarcinoma associated with Opisthorchis felineus liver fluke infection. Mordvinov VA; Minkova GA; Kovner AV; Ponomarev DV; Lvova MN; Zaparina O; Romanenko SA; Shilov AG; Pakharukova MY Life Sci; 2021 Jul; 277():119494. PubMed ID: 33862109 [TBL] [Abstract][Full Text] [Related]
47. Function association of enhanced expressed genes between Opisthorchis viverrini and non Opisthorchis viverrini-related cholangiocarcinoma. Wiwanitkit V Rev Esp Enferm Dig; 2008 Jul; 100(7):439-40. PubMed ID: 18808295 [No Abstract] [Full Text] [Related]
48. Knockout of liver fluke granulin, Ov-grn-1, impedes malignant transformation during chronic infection with Opisthorchis viverrini. Chaiyadet S; Tangkawattana S; Smout MJ; Ittiprasert W; Mann VH; Deenonpoe R; Arunsan P; Loukas A; Brindley PJ; Laha T PLoS Pathog; 2022 Sep; 18(9):e1010839. PubMed ID: 36137145 [TBL] [Abstract][Full Text] [Related]
49. Hepatic cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of patients with Opisthorchis viverrini-associated cholangiocarcinoma. Yongvanit P; Phanomsri E; Namwat N; Kampan J; Tassaneeyakul W; Loilome W; Puapairoj A; Khuntikeo N Parasitol Int; 2012 Mar; 61(1):162-6. PubMed ID: 21745589 [TBL] [Abstract][Full Text] [Related]
50. Update on the risk factors for opisthorchiasis and cholangiocarcinoma in Thailand. Prasopdee S; Rojthongpond T; Chitkoolsamphan Y; Pholhelm M; Yusuk S; Pattaraarchachai J; Butthongkomvong K; Kulsantiwong J; Phanaksri T; Kunjantarachot A; Tesana S; Sathavornmanee T; Thitapakorn V Parasites Hosts Dis; 2023 Nov; 61(4):463-470. PubMed ID: 38043542 [TBL] [Abstract][Full Text] [Related]
51. Proteomic analysis to identify plasma orosomucoid 2 and kinesin 18A as potential biomarkers of cholangiocarcinoma. Rucksaken R; Khoontawad J; Roytrakul S; Pinlaor P; Hiraku Y; Wongkham C; Pairojkul C; Boonmars T; Pinlaor S Cancer Biomark; 2012; 12(2):81-95. PubMed ID: 23396253 [TBL] [Abstract][Full Text] [Related]
52. Inflammatory response to liver fluke Opisthorchis viverrini in mice depends on host master coregulator MTA1, a marker for parasite-induced cholangiocarcinoma in humans. Nair SS; Bommana A; Pakala SB; Ohshiro K; Lyon AJ; Suttiprapa S; Periago MV; Laha T; Hotez PJ; Bethony JM; Sripa B; Brindley PJ; Kumar R Hepatology; 2011 Oct; 54(4):1388-97. PubMed ID: 21725997 [TBL] [Abstract][Full Text] [Related]
53. Aberrant GLUT1 Expression Is Associated With Carcinogenesis and Progression of Liver Fluke-associated Cholangiocarcinoma. Thamrongwaranggoon U; Sangkhamanon S; Seubwai W; Saranaruk P; Cha'on U; Wongkham S In Vivo; 2021; 35(1):267-274. PubMed ID: 33402473 [TBL] [Abstract][Full Text] [Related]
55. MRI and (1)H MRS findings of hepatobilary changes and cholangiocarcinoma development in hamsters infected with Opisthorchis viverrini and treated with N-nitrosodimethylamine. Hanpanich P; Pinlaor S; Charoensuk L; Yongvanit P; Chamgramol Y; Pairojkul C; Mairiang E Magn Reson Imaging; 2015 Nov; 33(9):1146-1155. PubMed ID: 26117689 [TBL] [Abstract][Full Text] [Related]
56. Plasma phosphoproteome and differential plasma phosphoproteins with opisthorchis viverrini-related cholangiocarcinoma. Kotawong K; Thitapakorn V; Roytrakul S; Phaonakrop N; Viyanant V; Na-Bangchang K Asian Pac J Cancer Prev; 2015; 16(3):1011-8. PubMed ID: 25735322 [TBL] [Abstract][Full Text] [Related]
57. Oxidative and nitrative DNA damage: key events in opisthorchiasis-induced carcinogenesis. Yongvanit P; Pinlaor S; Bartsch H Parasitol Int; 2012 Mar; 61(1):130-5. PubMed ID: 21704729 [TBL] [Abstract][Full Text] [Related]
58. Helicobacter pylori GroEL Seropositivity Is Associated with an Increased Risk of Opisthorchis viverrini-Associated Hepatobiliary Abnormalities and Cholangiocarcinoma. Jala I; Almanfaluthi ML; Laha T; Kanthawong S; Tangkawattana S; Saichua P; Suttiprapa S; Sripa B Korean J Parasitol; 2021 Aug; 59(4):363-368. PubMed ID: 34470087 [TBL] [Abstract][Full Text] [Related]
59. Melatonin suppresses eosinophils and Th17 cells in hamsters treated with a combination of human liver fluke infection and a chemical carcinogen. Wongsena W; Charoensuk L; Dangtakot R; Pinlaor P; Intuyod K; Pinlaor S Pharmacol Rep; 2018 Feb; 70(1):98-105. PubMed ID: 29331794 [TBL] [Abstract][Full Text] [Related]
60. Epigenetic Biomarkers and the Wnt/β-Catenin Pathway in Opisthorchis viverrini-associated Cholangiocarcinoma: A Scoping Review on Therapeutic Opportunities. Kafle A; Suttiprapa S; Muhammad M; Tenorio JCB; Mahato RK; Sahimin N; Loong SK PLoS Negl Trop Dis; 2024 Sep; 18(9):e0012477. PubMed ID: 39236081 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]